253 related articles for article (PubMed ID: 8334743)
1. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.
Brada M; Rajan B; Traish D; Ashley S; Holmes-Sellors PJ; Nussey S; Uttley D
Clin Endocrinol (Oxf); 1993 Jun; 38(6):571-8. PubMed ID: 8334743
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
[TBL] [Abstract][Full Text] [Related]
3. Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970-1988).
Jaffrain-Rea ML; Derome P; Bataini JP; Thomopoulos P; Bertagna X; Luton JP
Eur J Med; 1993; 2(7):398-403. PubMed ID: 8258027
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
Jalali R; Brada M; Perks JR; Warrington AP; Traish D; Burchell L; McNair H; Thomas DG; Robinson S; Johnston DG
Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy.
Hughes MN; Llamas KJ; Yelland ME; Tripcony LB
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1035-43. PubMed ID: 8262824
[TBL] [Abstract][Full Text] [Related]
6. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.
Tsang RW; Brierley JD; Panzarella T; Gospodarowicz MK; Sutcliffe SB; Simpson WJ
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):557-65. PubMed ID: 7928486
[TBL] [Abstract][Full Text] [Related]
8. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
[TBL] [Abstract][Full Text] [Related]
9. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland.
Milker-Zabel S; Debus J; Thilmann C; Schlegel W; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1279-86. PubMed ID: 11483339
[TBL] [Abstract][Full Text] [Related]
10. Recurrent pituitary adenomas after surgical resection: the role of radiation therapy.
Kovalic JJ; Grigsby PW; Fineberg BB
Radiology; 1990 Oct; 177(1):273-5. PubMed ID: 2399329
[TBL] [Abstract][Full Text] [Related]
11. [Hormonally inactive hypophyseal adenomas: the results and late sequelae after surgery and radiotherapy].
Grabenbauer GG; Fietkau R; Buchfelder M; Meyer M; Baumann J; Hensen J; Rummelt V; Fahlbusch R; Sauer R
Strahlenther Onkol; 1996 Apr; 172(4):193-7. PubMed ID: 8623081
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of radiotherapy for pituitary adenomas.
Snead FE; Amdur RJ; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):994-8. PubMed ID: 18403133
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of conventional radiation therapy in the management of pituitary adenoma.
Sasaki R; Murakami M; Okamoto Y; Kono K; Yoden E; Nakajima T; Nabeshima S; Kuroda Y
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1337-45. PubMed ID: 10889388
[TBL] [Abstract][Full Text] [Related]
14. Role of radiation therapy in clinical hormonally-active pituitary adenomas.
Tsang RW; Brierley JD; Panzarella T; Gospodarowicz MK; Sutcliffe SB; Simpson WJ
Radiother Oncol; 1996 Oct; 41(1):45-53. PubMed ID: 8961367
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity.
Erridge SC; Conkey DS; Stockton D; Strachan MW; Statham PF; Whittle IR; Grant R; Kerr GR; Gregor A
Radiother Oncol; 2009 Dec; 93(3):597-601. PubMed ID: 19900729
[TBL] [Abstract][Full Text] [Related]
16. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-45 Gy.
Zaugg M; Adaman O; Pescia R; Landolt AM
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):671-80. PubMed ID: 7790253
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for pituitary adenoma: long-term outcome and sequelae.
McCord MW; Buatti JM; Fennell EM; Mendenhall WM; Marcus RB; Rhoton AL; Grant MB; Friedman WA
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):437-44. PubMed ID: 9308948
[TBL] [Abstract][Full Text] [Related]
18. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
J Clin Endocrinol Metab; 2005 Feb; 90(2):800-4. PubMed ID: 15562021
[TBL] [Abstract][Full Text] [Related]
19. Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas.
Rieken S; Habermehl D; Welzel T; Mohr A; Lindel K; Debus J; Combs SE
Radiat Oncol; 2013 Jan; 8():18. PubMed ID: 23343416
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]